A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
Conditions:   Multiple Myeloma;   Refractory Multiple Myeloma;   Relapse Multiple Myeloma
Interventions:   Biological: MCARH125;   Biological: MCARH109
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 25, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments